EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD
129.52
-5.15 (-3.82%)
At close: 4:01PM EDT

129.52 -0.08 (-0.06%)
After hours: 4:12PM EDT

Stock chart is not supported by your current browser
Previous Close134.67
Open124.01
Bid128.80 x 500
Ask129.51 x 100
Day's Range123.00 - 130.75
52 Week Range100.20 - 143.22
Volume5,330,429
Avg. Volume1,387,191
Market Cap27.267B
Beta0.68
PE Ratio (TTM)47.97
EPS (TTM)2.70
Earnings DateApr 23, 2018 - Apr 27, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est146.37
Trade prices are not sourced from all markets
  • Edward Life Sciences drops on mixed earnings release
    CNBC Videosyesterday

    Edward Life Sciences drops on mixed earnings release

    CNBC's Kate Rogers reports on the quarterly earnings for Edward Life Sciences.

  • Cramer's lightning round: Edwards Lifesciences is simplif...
    CNBC Videos5 days ago

    Cramer's lightning round: Edwards Lifesciences is simplif...

    Jim Cramer flies through his take on callers' favorite stocks, including a biotech play.

  • Edwards Lifesciences (EW) Q1 Earnings Beat, Revenues Miss
    Zacks5 hours ago

    Edwards Lifesciences (EW) Q1 Earnings Beat, Revenues Miss

    Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q1.

  • Premarket: Futures Improve As Boeing, Twitter, 3 Chip Stocks Soar
    Investor's Business Daily8 hours ago

    Premarket: Futures Improve As Boeing, Twitter, 3 Chip Stocks Soar

    Premarket trading turned mixed on Wednesday as Boeing, Twitter and Cree gained, Alphabet got an upgrade and Comcast bid $31 billion for Britain's Sky.

  • What Drove Edwards Lifesciences’ 1Q18 Earnings?
    Market Realist9 hours ago

    What Drove Edwards Lifesciences’ 1Q18 Earnings?

    Japan is the company’s highest growth region outside the United States. Therapy adoption continues to be the major factor driving Edwards’ THVT segment sales in 1Q18. For more on related developments, read Recent Developments at Edwards Lifesciences.

  • Edwards Lifesciences Missed Sales Estimates in 1Q18
    Market Realist9 hours ago

    Edwards Lifesciences Missed Sales Estimates in 1Q18

    Edwards Lifesciences Stock Fell on Missed 1Q18 Sales EstimatesEdwards Lifesciences releases 1Q18 results

  • InvestorPlace9 hours ago

    3 Stocks to Watch on Wednesday: Edwards Lifesciences Corp (EW), Illumina, Inc. (ILMN) and Tesla Inc (TSLA)

    Edwards Lifesciences Corp (NYSE:EW) and Illumina, Inc. (NASDAQ:ILMN) reported their quarterly earnings results after hours Tuesday, while Tesla Inc (NASDAQ:TSLA) finds itself in hot waters over a contract dispute. Edward Lifesciences reported its latest quarterly results after hours yesterday. The company announced that the first-quarter global sales of its heart valves, a metric that marks the company’s most important growth driver, increased 2.3% year-over-year to $551.5 million.

  • Thomson Reuters StreetEvents12 hours ago

    Edited Transcript of EW earnings conference call or presentation 24-Apr-18 9:00pm GMT

    Q1 2018 Edwards Lifesciences Corp Earnings Call

  • Reuters22 hours ago

    Edward Lifesciences' heart valve sales in Europe disappoint, shares fall

    Edwards Lifesciences Corp's first-quarter sales for transcatheter heart valves missed Wall Street targets on Tuesday, as the medical device maker lost market share in Europe to its rival, Medtronic Plc. The company's shares fell as much as 8.1 percent in after-market trading as sales of its premium non-invasive device, used to replace diseased aortic valves without open-heart surgery, is its biggest growth driver. "Procedure growth in Europe was double digits this quarter, while our growth was lower due to a year-over-year shift in share to our largest competitor," Chief Executive Officer Michael A. Mussallem said on a call with analysts.

  • MarketWatch22 hours ago

    Edwards Lifesciences stock drops 8% after forecast misses

    Edwards Lifesciences Corp. shares dropped in late trading Tuesday after the company provided a disappointing forecast. The company reported first-quarter earnings of 96 cents a share on sales of $894.8 ...

  • Despite Today's Market, Baozun And Solaredge Technologies Join Sector Leaders
    Investor's Business Daily22 hours ago

    Despite Today's Market, Baozun And Solaredge Technologies Join Sector Leaders

    Here’s a list of all the top-rated growth stocks that have just been added to the IBD 50, IBD Big Cap 20, Sector Leaders, Stock Spotlight and IPO leaders.

  • Edwards Lifesciences Tanks After Heart-Valve Sales Lag Expectations
    Investor's Business Daily23 hours ago

    Edwards Lifesciences Tanks After Heart-Valve Sales Lag Expectations

    For the first quarter, Edwards reported $937.5 million in adjusted sales and adjusted profit of $1.22 per share.

  • CNBC23 hours ago

    After-hours buzz: TXN, WYNN, EW & more

    See which stocks are posting big moves after the bell.

  • The Hottest Earnings Charts This Week
    Zacksyesterday

    The Hottest Earnings Charts This Week

    All eyes will be on these hot stocks during this busy earnings week.

  • Associated Pressyesterday

    Edwards Lifesciences: 1Q Earnings Snapshot

    On a per-share basis, the Irvine, California-based company said it had net income of 96 cents. Earnings, adjusted for non-recurring costs, were $1.22 per share. The results beat Wall Street expectations. ...

  • Reutersyesterday

    Edwards Lifesciences reports 1.3 pct rise in quarterly sales

    Medical device maker Edwards Lifesciences Corp reported a 1.3 percent rise in first-quarter revenue on Tuesday on higher demand for transcatheter heart valves, its biggest business. The company's net profit ...

  • Edwards Lifesciences Reports First Quarter Results
    PR Newswireyesterday

    Edwards Lifesciences Reports First Quarter Results

    IRVINE, Calif. , April 24, 2018 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, ...

  • ACCESSWIREyesterday

    Edwards Lifesciences Corporation to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / April 24, 2018 / Edwards Lifesciences Corporation (NYSE: EW ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 24, 2018 at 5:00 PM Eastern ...

  • Will BSX’s 1Q18 Results Support Its Upward Trend?
    Market Realistyesterday

    Will BSX’s 1Q18 Results Support Its Upward Trend?

    Over the last month, BSX stock has registered a rise of ~4.2%. The company came out on top in patent infringement litigation against Edwards Lifesciences (EW), for which a hearing is scheduled in May at the German Court of Appeal. On April 16, Boston Scientific announced its acquisition of Nvision Medical Corporation for a cash payment of $150 million and an additional milestone-based payment over the next four years amounting to $125 million.

  • Will Boston Scientific Beat 1Q18 Earnings Estimates?
    Market Realistyesterday

    Will Boston Scientific Beat 1Q18 Earnings Estimates?

    In 1Q18, Boston Scientific (BSX) is expected to report adjusted EPS (earnings per share) of $0.32, representing YoY (year-over-year) growth of ~8.7%. The company reported adjusted EPS of $0.34 in fiscal 4Q17, and it had registered YoY growth of ~14.8%. The adjusted EPS were in line with Wall Street expectations.

  • Boston Scientific’s 1Q18 Revenues: What to Expect
    Market Realist2 days ago

    Boston Scientific’s 1Q18 Revenues: What to Expect

    On April 25, Boston Scientific (BSX) plans to announce its 1Q18 earnings results—the quarter that ended on March 31. According to Wall Street analysts’ estimates, the company’s 1Q18 revenues are expected to come in at $2.34 billion, representing YoY (year-over-year) growth of ~8.4%.

  • What to Expect from Edward Lifesciences’ 1Q18 Earnings
    Market Realist2 days ago

    What to Expect from Edward Lifesciences’ 1Q18 Earnings

    Edwards Lifesciences (EW) will announce its 1Q18 earnings results for the quarter ended March 31, 2018, on April 24. The company is a leader in the TAVR (transcatheter aortic valve replacement) market space and manufactures the market-leading Sapien family of valves. The company reported robust 4Q17 and fiscal 2017 results on February 1, 2018, which triggered a 7% of stock price rise.

  • Boston Scientific: The Word on Wall Street ahead of 1Q18 Earnings
    Market Realist2 days ago

    Boston Scientific: The Word on Wall Street ahead of 1Q18 Earnings

    The company has been growing aggressively through strategic acquisitions. This month, the company announced the acquisition of Nvision Medical Corporation in the area of women’s health and Securus Medical in the area of electrophysiology. The company is slated to announce its 1Q18 earnings results on April 25. In this article, let’s discuss the company’s Wall Street recommendations and target prices for the next 12 months.

  • Why Earnings Season Could Be Great for Edwards Lifesciences (EW)
    Zacks2 days ago

    Why Earnings Season Could Be Great for Edwards Lifesciences (EW)

    Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

  • CNBC5 days ago

    Cramer's lightning round: Edwards Lifesciences is simplifying heart surgery, and it's a buy

    It's that time again! "Mad Money" host Jim Cramer rang the lightning round bell, which means he gave his take on callers' favorite stocks at rapid speed. Edwards Lifesciences Corp. EW : "Oh, that is a great company and they have the best device. Align Technology ALGN : "The stock is breaking down here.